|
中文名称 |
英文名称 |
CAS号 |
G007-LK | G007-LK | 1380672-07-0 |
AZD-3293 | Dispiro[cyclohexane-1,2-[2H]indene-1(3H),2-[2H]iMidazol]-4-aMine, 4-Methoxy-5-Methyl-6-[5-(1-propyn-1-yl)-3-pyridinyl]-, (1α,1R,4β)- | 1383982-64-6 |
2,6-DIMETHYLPHENYL 2,4-DIMETHOXYPHENYL(2-(4-(4-METHYLPIPERAZIN-1-YL)PHENYLAMINO)PYRIMIDIN-4-YL)CARBAMATE | WH-4-023 | 837422-57-8 |
2 - [ 4- [ 4 -(三氟甲基)苯甲酰胺基] ] ]苯甲基4,6 -二(二甲氨基) -嘧啶-5-乙酸 | AP-761 | 1093108-50-9 |
PEFICITINIB | Peficitinib | 944118-01-8 |
N/A | MPI-0479605 | 1246529-32-7 |
8-[(1R)-1-[(3,5-二氟苯基)氨基]乙基]-N,N-二甲基-2-(4-吗啉基)-4-氧代-4H-1-苯并吡喃-6-甲酰胺 | AZD8186 | 1627494-13-6 |
RG120 | RG120 | 1448347-49-6 |
3,4-二氯-2-苯并吡喃-1-酮 | 3,4-DICHLOROISOCOUMARIN | 51050-59-0 |
9-(四氢-2-呋喃)腺膘呤 | SQ 22,536 | 17318-31-9 |
MG132,蛋白酶体抑制剂 | MG-132 | 133407-82-6 |
CC-223 | CC-223 | 1228013-30-6 |
QUISINOSTAT (JNJ-26481585) 2HCL | JNJ26854165(Quisinostat) 2HCl | 875320-31-3 |
GSK591 (EPZ-015866) | GSK591 | 1616391-87-7 |
1-[[(2S)-3-(二乙基氨基)-2-羟基丙基]氨基]-4-[[(2S)-2-环氧乙烷基甲基]氨基]-9,10-蒽醌 | BDA-366 | 1909226-00-1 |
|
|